<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>While <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>) and non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL) have long been regarded as distinct disease entities, recent observations suggest a closer association </plain></SENT>
<SENT sid="1" pm="."><plain>The analysis of cases in which these diagnoses are made in the same anatomic site (composite <z:hpo ids='HP_0002665'>lymphomas</z:hpo>) or in separate sites (simultaneous or sequential <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> and NHL) indicates that this phenomenon occurs more frequently than would be expected by chance alone </plain></SENT>
<SENT sid="2" pm="."><plain>The most common form of composite <z:hpo ids='HP_0002665'>lymphoma</z:hpo> is coexistent nodular lymphocyte-predominant <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> (NLPHD) and large cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (LCL) of B <z:mp ids='MP_0005384'>cell phenotype</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>This finding is consistent with a B cell origin for the abnormal cells in NLPHD, suggesting that LCL represents a form of histologic progression, with the existence of a clonal relationship between the two components </plain></SENT>
<SENT sid="4" pm="."><plain>The association of other forms of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> (nodular <z:mp ids='MP_0000612'>sclerosis</z:mp> or mixed-cellularity) and NHL is less common, but still significant </plain></SENT>
<SENT sid="5" pm="."><plain>As with NLPHD and LCL, one may observe composite <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, or the diagnosis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> may precede or follow the diagnosis of NHL </plain></SENT>
<SENT sid="6" pm="."><plain>The vast majority of NHLs associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> are of B cell origin, most commonly follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>An association between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> and B cell <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> (CLL) is also observed </plain></SENT>
<SENT sid="8" pm="."><plain>In selected cases, Reed-Sternberg (RS) cells are seen in a background of otherwise typical CLL, and some of these patients have progressed to disseminated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>These findings suggest that, at least in some cases, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> may be clonally related to an underlying B cell <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e>, and that the RS cell may be an altered B lymphocyte.(ABSTRACT TRUNCATED AT 250 WORDS) </plain></SENT>
</text></document>